By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Auris Medical AG 

Falknerstrasse 4

Basel    4001  Switzerland
Phone: 41-61-201-13-50 Fax: 41-61-201-13-51



Start Up

Company News
Auris Med (EARS) Announces AAO-HNSF Annual Meeting Activities 9/13/2016 10:53:44 AM
Auris Med (EARS) Achieves Midpoint For Enrollment In Phase 3 Trial Of AM-111 In Sudden Deafness 9/9/2016 10:21:01 AM
Auris Med (EARS) Provides Business Update And Reports Second Quarter 2016 Financial Results 8/18/2016 8:49:52 AM
Auris Med (EARS)'s Tinnitus Drug Misses Main Goals in Study; Shares Sink 8/18/2016 6:19:15 AM
Auris Medical AG (EARS) To Announce Second Quarter 2016 Financial Results And Host Conference Call And Webcast On Thursday, August 18, 2016 8/16/2016 8:53:51 AM
Auris Medical AG (EARS) Secures Loan Facility Of Up To $20 Million 7/20/2016 9:13:26 AM
FDA Grants Auris Medical AG (EARS) Fast Track Designation For Keyzilen In Acute Peripheral Tinnitus 7/18/2016 9:24:38 AM
Auris Medical AG (EARS) To Present At Cantor Fitzgerald's 2nd Annual Healthcare Conference On Tuesday, July 12 7/8/2016 10:18:33 AM
Auris Medical AG (EARS) Completes Enrollment Of Phase 3 TACTT3 Trial With Keyzilen In Acute And Post-Acute Inner Ear Tinnitus 6/28/2016 11:34:26 AM
Auris Medical AG (EARS) Initiates ASSENT Phase 3 Trial Of AM-111 For Treatment Of Sudden Deafness 6/17/2016 9:42:17 AM